Drug targeting inflammation helps improve the effects of stroke

Share this article:

A new delivery method for a drug delivered to the central nervous system holds hope for treating brain inflammation that comes after a stroke, researchers have found. The effect can be realized years after a stroke, they said.

The drug, etanercept, has been successful in treating other inflammatory diseases, such as rheumatoid arthritis. The drug works by neutralizing tumor necrosis factor, a cytokine that initiates and amplifies inflammation.

When etanercept was administered to three stroke patients, all demonstrated improvement in areas such as motor function, gait, hand function, sensory deficits, spatial perception, speech and cognition within 10 minutes. The results of the study were published in Tuesday's issue of CNS Drugs.
Share this article:

More in News

Bill addressing admission status receives praise

A bill that would require hospitals to give patients a formal notice of their admission status has received strong support from healthcare associations.

Increased 'bed taxes' on nursing facilities warrants stricter federal oversight, report states

States have been increasingly taxing skilled nursing facilities and other healthcare providers to fund Medicaid in recent years, and federal authorities should look more closely at this trend, according to a government report released Tuesday.

Last chance: Tech Awards deadline arrives

Last chance: Tech Awards deadline arrives

There are hours left for innovative long-term care providers to enter the third annual McKnight's Excellence in Technology Awards. Submissions will be accepted until the stroke of midnight tonight.